LifeVantage Corporation Logo

LifeVantage Corporation

LFVN

(1.8)
Stock Price

10,30 USD

3.87% ROA

9.5% ROE

27.63x PER

Market Cap.

71.706.396,00 USD

48.2% DER

9.49% Yield

1.4% NPM

LifeVantage Corporation Stock Analysis

LifeVantage Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

LifeVantage Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (38%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

ROE in an average range (7.7%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (3.87%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (2.04x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 Dividend Growth

The company's dividend growth has been consistently strong over the past three years, with annual increases that demonstrate its commitment to rewarding shareholders.

6 Buffet Intrinsic Value

The company's stock seems undervalued (445) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

LifeVantage Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

LifeVantage Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

LifeVantage Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

LifeVantage Corporation Revenue
Year Revenue Growth
1997 0
1998 0 0%
1999 0 0%
2000 1 100%
2001 1 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 2.353.795 100%
2006 7.165.819 67.15%
2007 5.050.988 -41.87%
2008 3.200.174 -57.83%
2009 4.141.304 22.73%
2010 11.478.460 63.92%
2011 38.919.223 70.51%
2012 126.182.848 69.16%
2013 208.178.000 39.39%
2014 213.968.000 2.71%
2015 190.336.000 -12.42%
2016 206.540.000 7.85%
2017 199.489.000 -3.53%
2018 203.204.000 1.83%
2019 225.958.000 10.07%
2020 232.915.000 2.99%
2021 220.181.000 -5.78%
2022 206.360.000 -6.7%
2023 213.398.000 3.3%
2024 205.456.000 -3.87%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

LifeVantage Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 37.933 100%
2006 114.163 66.77%
2007 245.561 53.51%
2008 324.106 24.23%
2009 224.366 -44.45%
2010 392.691 42.86%
2011 508.603 22.79%
2012 1.359.055 62.58%
2013 2.948.000 53.9%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

LifeVantage Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 15.204 100%
2001 24.730 38.52%
2002 16.350 -51.25%
2003 9.409 -73.77%
2004 0 0%
2005 3.255.528 100%
2006 8.164.079 60.12%
2007 7.347.105 -11.12%
2008 3.763.799 -95.2%
2009 6.588.414 42.87%
2010 7.765.331 15.16%
2011 7.516.106 -3.32%
2012 16.396.631 54.16%
2013 32.471.000 49.5%
2014 56.801.000 42.83%
2015 57.353.000 0.96%
2016 56.074.000 -2.28%
2017 64.922.000 13.63%
2018 59.840.000 -8.49%
2019 69.551.000 13.96%
2020 67.914.000 -2.41%
2021 60.838.000 -11.63%
2022 63.425.000 4.08%
2023 71.065.000 10.75%
2024 71.848.000 1.09%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

LifeVantage Corporation EBITDA
Year EBITDA Growth
1997 -19.842
1998 -24.037 17.45%
1999 -78.712 69.46%
2000 -15.203 -417.74%
2001 -24.729 38.52%
2002 -16.350 -51.25%
2003 -9.409 -73.77%
2004 -12.242 23.14%
2005 2.327.314 100.53%
2006 -2.603.755 189.38%
2007 -3.633.416 28.34%
2008 -1.583.117 -129.51%
2009 -7.625.396 79.24%
2010 -10.168.723 25.01%
2011 52.371.178 119.42%
2012 21.977.655 -138.29%
2013 14.462.000 -51.97%
2014 21.792.000 33.64%
2015 13.740.000 -58.6%
2016 12.005.000 -14.45%
2017 3.480.000 -244.97%
2018 10.004.000 65.21%
2019 9.553.000 -4.72%
2020 14.781.000 35.37%
2021 17.249.000 14.31%
2022 6.906.000 -149.77%
2023 4.259.000 -62.15%
2024 6.668.000 36.13%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

LifeVantage Corporation Gross Profit
Year Gross Profit Growth
1997 0
1998 0 0%
1999 0 0%
2000 1 100%
2001 1 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 1.960.244 100%
2006 5.674.487 65.46%
2007 4.028.196 -40.87%
2008 2.504.788 -60.82%
2009 3.288.500 23.83%
2010 9.572.468 65.65%
2011 33.001.829 70.99%
2012 108.130.697 69.48%
2013 171.535.000 36.96%
2014 180.774.000 5.11%
2015 162.326.000 -11.36%
2016 172.608.000 5.96%
2017 166.033.000 -3.96%
2018 168.356.000 1.38%
2019 187.985.000 10.44%
2020 194.951.000 3.57%
2021 181.994.000 -7.12%
2022 168.263.000 -8.16%
2023 170.011.000 1.03%
2024 164.736.000 -3.2%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

LifeVantage Corporation Net Profit
Year Net Profit Growth
1997 -19.842
1998 -24.037 17.45%
1999 -78.712 69.46%
2000 -15.204 -417.71%
2001 -24.730 38.52%
2002 -16.350 -51.25%
2003 -9.430 -73.38%
2004 -12.242 22.97%
2005 -5.822.397 99.79%
2006 -2.734.501 -112.92%
2007 -3.693.578 25.97%
2008 -2.054.439 -79.79%
2009 -9.114.634 77.46%
2010 -11.048.328 17.5%
2011 -50.791.750 78.25%
2012 12.469.077 507.34%
2013 7.608.000 -63.89%
2014 11.383.000 33.16%
2015 6.987.000 -62.92%
2016 6.019.000 -16.08%
2017 1.608.000 -274.32%
2018 5.761.000 72.09%
2019 7.429.000 22.45%
2020 11.549.000 35.67%
2021 12.894.000 10.43%
2022 3.120.000 -313.27%
2023 2.540.000 -22.83%
2024 2.516.000 -0.95%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

LifeVantage Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 -2 100%
2006 -1 0%
2007 -1 100%
2008 -1 0%
2009 -2 100%
2010 -1 0%
2011 -5 75%
2012 1 0%
2013 0 0%
2014 1 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

LifeVantage Corporation Free Cashflow
Year Free Cashflow Growth
1997 -1.382
1998 111 1345.05%
1999 -807 113.75%
2000 -127.382 99.37%
2001 -19.730 -545.63%
2002 -15.021 -31.35%
2003 -9.995 -50.29%
2004 -3.035 -229.32%
2005 -2.972.036 99.9%
2006 -1.051.996 -182.51%
2007 -3.188.256 67%
2008 -818.075 -289.73%
2009 -5.452.412 85%
2010 -4.546.187 -19.93%
2011 4.516.958 200.65%
2012 17.142.676 73.65%
2013 5.582.000 -207.11%
2014 9.857.000 43.37%
2015 12.062.000 18.28%
2016 5.424.000 -122.38%
2017 5.542.000 2.13%
2018 8.607.000 35.61%
2019 15.283.000 43.68%
2020 15.645.000 2.31%
2021 12.532.000 -24.84%
2022 6.429.000 -94.93%
2023 3.761.000 -70.94%
2024 3.632.000 -3.55%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

LifeVantage Corporation Operating Cashflow
Year Operating Cashflow Growth
1997 -1.382
1998 111 1345.05%
1999 -807 113.75%
2000 -127.382 99.37%
2001 -19.730 -545.63%
2002 -15.021 -31.35%
2003 -9.995 -50.29%
2004 -3.035 -229.32%
2005 -2.912.977 99.9%
2006 -915.629 -218.14%
2007 -3.128.090 70.73%
2008 -747.777 -318.32%
2009 -5.206.904 85.64%
2010 -4.499.483 -15.72%
2011 4.680.925 196.12%
2012 19.388.948 75.86%
2013 10.662.000 -81.85%
2014 12.105.000 11.92%
2015 13.221.000 8.44%
2016 5.986.000 -120.87%
2017 6.597.000 9.26%
2018 13.256.000 50.23%
2019 17.789.000 25.48%
2020 18.326.000 2.93%
2021 16.273.000 -12.62%
2022 7.959.000 -104.46%
2023 6.828.000 -16.56%
2024 4.765.000 -43.29%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

LifeVantage Corporation Capital Expenditure
Year Capital Expenditure Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 59.059 100%
2006 136.367 56.69%
2007 60.166 -126.65%
2008 70.298 14.41%
2009 245.508 71.37%
2010 46.704 -425.67%
2011 163.967 71.52%
2012 2.246.272 92.7%
2013 5.080.000 55.78%
2014 2.248.000 -125.98%
2015 1.159.000 -93.96%
2016 562.000 -106.23%
2017 1.055.000 46.73%
2018 4.649.000 77.31%
2019 2.506.000 -85.51%
2020 2.681.000 6.53%
2021 3.741.000 28.33%
2022 1.530.000 -144.51%
2023 3.067.000 50.11%
2024 1.133.000 -170.7%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

LifeVantage Corporation Equity
Year Equity Growth
1997 129.696
1998 105.659 -22.75%
1999 26.947 -292.1%
2000 11.743 -129.47%
2001 44.013 73.32%
2002 38.163 -15.33%
2003 35.733 -6.8%
2004 23.491 -52.11%
2005 10.978.112 99.79%
2006 8.284.659 -32.51%
2007 2.713.388 -205.33%
2008 3.169.250 14.38%
2009 -6.854.094 146.24%
2010 -16.174.994 57.63%
2011 -20.808.202 22.27%
2012 28.283.169 173.57%
2013 33.945.000 16.68%
2014 3.990.000 -750.75%
2015 3.325.000 -20%
2016 12.131.000 72.59%
2017 14.527.000 16.49%
2018 21.947.000 33.81%
2019 27.199.000 19.31%
2020 33.254.000 18.21%
2021 36.807.000 9.65%
2022 31.516.000 -16.79%
2023 34.649.000 9.04%
2024 29.294.000 -18.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

LifeVantage Corporation Assets
Year Assets Growth
1997 308.521
1998 308.632 0.04%
1999 183.125 -68.54%
2000 35.743 -412.34%
2001 44.013 18.79%
2002 39.492 -11.45%
2003 36.497 -8.21%
2004 37.962 3.86%
2005 11.843.312 99.68%
2006 10.447.878 -13.36%
2007 3.914.295 -166.92%
2008 4.549.036 13.95%
2009 5.715.672 20.41%
2010 6.227.224 8.21%
2011 12.498.512 50.18%
2012 44.527.836 71.93%
2013 55.484.000 19.75%
2014 53.999.000 -2.75%
2015 40.879.000 -32.09%
2016 50.259.000 18.66%
2017 45.249.000 -11.07%
2018 51.142.000 11.52%
2019 55.273.000 7.47%
2020 58.877.000 6.12%
2021 78.732.000 25.22%
2022 70.706.000 -11.35%
2023 66.123.000 -6.93%
2024 66.604.000 0.72%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

LifeVantage Corporation Liabilities
Year Liabilities Growth
1997 178.825
1998 202.973 11.9%
1999 156.178 -29.96%
2000 24.000 -550.74%
2001 0 0%
2002 1.329 100%
2003 764 -73.95%
2004 14.471 94.72%
2005 865.200 98.33%
2006 2.163.219 60%
2007 1.200.907 -80.13%
2008 1.379.786 12.96%
2009 12.569.766 89.02%
2010 22.402.218 43.89%
2011 33.306.714 32.74%
2012 16.244.667 -105.03%
2013 21.539.000 24.58%
2014 50.009.000 56.93%
2015 37.554.000 -33.17%
2016 38.128.000 1.51%
2017 30.722.000 -24.11%
2018 29.195.000 -5.23%
2019 28.074.000 -3.99%
2020 25.623.000 -9.57%
2021 41.925.000 38.88%
2022 39.190.000 -6.98%
2023 31.474.000 -24.52%
2024 37.310.000 15.64%

LifeVantage Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
16.99
Net Income per Share
0.2
Price to Earning Ratio
27.63x
Price To Sales Ratio
0.34x
POCF Ratio
5.47
PFCF Ratio
7.58
Price to Book Ratio
2.41
EV to Sales
0.32
EV Over EBITDA
10.83
EV to Operating CashFlow
5.21
EV to FreeCashFlow
7.12
Earnings Yield
0.04
FreeCashFlow Yield
0.13
Market Cap
0,07 Bil.
Enterprise Value
0,07 Bil.
Graham Number
3.28
Graham NetNet
-0.72

Income Statement Metrics

Net Income per Share
0.2
Income Quality
5.06
ROE
0.08
Return On Assets
0.05
Return On Capital Employed
0.06
Net Income per EBT
0.75
EBT Per Ebit
1.69
Ebit per Revenue
0.01
Effective Tax Rate
0.25

Margins

Sales, General, & Administrative to Revenue
0.34
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.8
Operating Profit Margin
0.01
Pretax Profit Margin
0.02
Net Profit Margin
0.01

Dividends

Dividend Yield
0.09
Dividend Yield %
9.49
Payout Ratio
2.64
Dividend Per Share
0.54

Operating Metrics

Operating Cashflow per Share
1.03
Free CashFlow per Share
0.75
Capex to Operating CashFlow
-0.27
Capex to Revenue
-0.02
Capex to Depreciation
-0.99
Return on Invested Capital
0.03
Return on Tangible Assets
0.04
Days Sales Outstanding
4.55
Days Payables Outstanding
56.58
Days of Inventory on Hand
131.41
Receivables Turnover
80.28
Payables Turnover
6.45
Inventory Turnover
2.78
Capex per Share
-0.28

Balance Sheet

Cash per Share
1,47
Book Value per Share
2,34
Tangible Book Value per Share
2.3
Shareholders Equity per Share
2.34
Interest Debt per Share
1.14
Debt to Equity
0.48
Debt to Assets
0.21
Net Debt to EBITDA
-0.69
Current Ratio
1.7
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.48
Working Capital
0,02 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
15889500
Debt to Market Cap
0.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

LifeVantage Corporation Dividends
Year Dividends Growth
2022 0
2023 1 0%

LifeVantage Corporation Profile

About LifeVantage Corporation

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.

CEO
Mr. Steven R. Fife
Employee
248
Address
3300 North Triumph Boulevard
Lehi, 84043

LifeVantage Corporation Executives & BODs

LifeVantage Corporation Executives & BODs
# Name Age
1 Ms. Alissa Neufeld
General Counsel & Corporate Secretary
70
2 Mr. Steven R. Fife
President, Chief Executive Officer & Director
70
3 Ms. Kristen Cunningham
Chief Sales Officer
70
4 Ms. Michelle Oborn-Virchow
Chief People Officer
70
5 Mr. Carl A. Aure
Chief Financial Officer
70
6 Ms. Julie Boyster
Chief Marketing Officer
70
7 Mr. Eric E. Marchant
Vice President of Compliance
70
8 Chris Taylor
Director of Communications
70
9 Ms. Calli Mott
Senior Vice President of Distributor Experience
70
10 Mr. Eiichi Shiokawa
Managing Director - Japan
70

LifeVantage Corporation Competitors